Benzinga | Feb 25, 2021 07:10AM EST

Agios Pharmaceuticals Q4 EPS $(1.41) Misses $(1.33) Estimate, Sales $44.05M Beat $40.17M Estimate

Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.33) by 6.02 percent. This is a 11.88 percent increase over losses of $(1.60) per share from the same period last year. The company reported quarterly sales of $44.05 million which beat the analyst consensus estimate of $40.17 million by 9.66 percent. This is a 24.29 percent increase over sales of $35.44 million the same period last year.